BDBM310904 3-methoxy-N-[4-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]propanamide::US10150767, Example 7
SMILES: COCCC(=O)Nc1ccc(cc1)-c1cn(C)c(=O)c2[nH]ccc12
InChI Key: InChIKey=IPDOQOMGRNAULI-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cat eye syndrome critical region protein 2 [424-538] (Homo sapiens (Human)) | BDBM310904![]() (3-methoxy-N-[4-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]py...) | PDB GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc.; Constellation Pharmaceuticals Inc. US Patent | Assay Description His/Flag epitope tagged CECR2424-538 was cloned, expressed, and purified to homogeneity. CECR2 binding and inhibition was assessed by monitoring the ... | US Patent US10150767 (2018) BindingDB Entry DOI: 10.7270/Q2V98B5W | |||||||||||
More data for this Ligand-Target Pair |